Science Explorer Back to mapMap
Discussion
Company · Anyang-si · South Korea

Caregen (South Korea)

caregen.comROR OpenAlex
Research works
7
▲ 210% vs 2018-21
Citations
122
16.4 per fractional work
Top-10% rate
4.4%
all institutions 10.0%
Open access
81%
world 40%
International
9%
world 18%
Caregen (South Korea)

Not ranked overall: Caregen (South Korea) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Caregen (South Korea) work in?

In all years, 46% of research at Caregen (South Korea) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (33%), Biochemistry, Genetics and Molecular Biology (31%), Nursing (9%). It does 1.4× the world's share of Life Sciences.

Health Sciences: 3 fractional works · 46.1% of its workMedicine: 2 fractional works · 32.7% of its workDermatology: 0 fractional works · 6.6% of its workUrology: 0 fractional works · 6.6% of its workPhysiology: 0 fractional works · 5.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 5.1% of its workBiochemistry: 0 fractional works · 2.3% of its workPathology and Forensic Medicine: 0 fractional works · 2.3% of its workEpidemiology: 0 fractional works · 1.7% of its workOncology: 0 fractional works · 1.5% of its workRehabilitation: 0 fractional works · 1.5% of its workNursing: 1 fractional works · 9.0% of its workNutrition and Dietetics: 1 fractional works · 9.0% of its workHealth Professions: 0 fractional works · 4.4% of its workGeneral Health Professions: 0 fractional works · 4.4% of its workLife Sciences: 3 fractional works · 39.9% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 30.9% of its workMolecular Biology: 2 fractional works · 22.8% of its workCell Biology: 0 fractional works · 4.4% of its workCancer Research: 0 fractional works · 3.7% of its workNeuroscience: 0 fractional works · 5.4% of its workSensory Systems: 0 fractional works · 4.4% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.9% of its workAgricultural and Biological Sciences: 0 fractional works · 2.3% of its workFood Science: 0 fractional works · 2.3% of its workImmunology and Microbiology: 0 fractional works · 1.3% of its workImmunology: 0 fractional works · 1.3% of its workSocial Sciences: 1 fractional works · 9.0% of its workEconomics, Econometrics and Finance: 1 fractional works · 9.0% of its workEconomics and Econometrics: 1 fractional works · 9.0% of its workPhysical Sciences: 0 fractional works · 5.1% of its workEngineering: 0 fractional works · 5.1% of its workBiomedical Engineering: 0 fractional works · 4.4% of its workBuilding and Construction: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKCaregen (SouthKorea)7fractional works, all years
Life Sciences40%Physical Sciences5%Health Sciences46%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine232.7%
    2. Nursing19.0%
    3. Health Professions04.4%
    1. Biochemistry, Genetics and Molecular Biology230.9%
    2. Neuroscience05.4%
    3. Agricultural and Biological Sciences02.3%
    4. Immunology and Microbiology01.3%
    1. Economics, Econometrics and Finance19.0%
    1. Engineering05.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.68× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 2.20× its world share, 0 worksImmunology and Micro…Neuroscience: 5.74× its world share, 0 worksNeuroscienceEngineering: 0.58× its world share, 0 worksEngineeringMedicine: 1.61× its world share, 1 worksMedicineNursing: 15.85× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 15.8×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Nursing15.85×0 works
  2. Biochemistry, Genetics and Molecular Biology7.68×2 works
  3. Neuroscience5.74×0 works
  4. Immunology and Microbiology2.20×0 works
  5. Medicine1.61×1 works
  6. Engineering0.58×0 works

What are the most cited papers from Caregen (South Korea)?

The most cited paper from Caregen (South Korea) is "Ripe fruits of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells" (Young‐Ok Son, J Kim, Ji-Youn Lim et al., 2003), with 154 citations. Next come "Crosstalk between endothelial cells and dermal papilla entails hair regeneration and angiogenesis during aging" (38) and "Cosmeceutical product consisting of biomimetic peptides: antiaging effects in vivo and in vitro" (29).

Most cited papers
#PaperReleasedCitations
1 Ripe fruits of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells Young‐Ok Son, J Kim, Ji-Youn Lim et al. · Food and Chemical Toxicology 22 Jul 2003 154
2 Crosstalk between endothelial cells and dermal papilla entails hair regeneration and angiogenesis during aging Siyi Zhou, Zeming Li, Xinzhu Li et al. · Journal of Advanced Research Open access 6 May 2024 38
3 Cosmeceutical product consisting of biomimetic peptides: antiaging effects in vivo and in vitro Zarema Gazitaeva, А. О. Дробинцева, Yongji Chung . et al. · Clinical Cosmetic and Investigational Dermatology Open access 2017 29
4 Inhibitory Effects of Glycoprotein-120 (G-120) from Ulmus davidiana Nakai on Cell Growth and Activation of Matrix Metalloproteinases Young‐Ok Son, Kyung‐Yeol Lee, Ki‐Choon Choi et al. · Molecules and Cells Open access Oct 2004 11
5 The cost of end-of-life care in South Korea H. C. Shin, Mi‐Young Choi, Byongho Tchoe · Health Policy and Management Open access 31 Mar 2012 9
All 12 most cited papers, with filters and sorting

Which research topics does Caregen (South Korea) publish most on?

By volume in 2022-now: Hair Growth and Disorders, Muscle Physiology and Disorders, Biochemical Analysis and Sensing Techniques and Hearing, Cochlea, Tinnitus, Genetics.

Hair Growth and Disorders0Hair Growth and Disorders: 0 fractional worksMuscle Physiology and Di…0Muscle Physiology and Disorders: 0 fractional worksBiochemical Analysis and Sensing Techniques: 0 fractional worksHearing, Cochlea, Tinnitus, Genetics: 0 fractional worksPeroxisome Proliferator-Activated Receptors: 0 fractional worksNutrition and Health in Aging: 0 fractional worksMetabolism, Diabetes, and Cancer: 0 fractional worksWnt/β-catenin signaling …0Wnt/β-catenin signaling in development and cancer: 0 fractional worksMuscle activation and electromyography studies: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional works
UrologyMolecular BiologyNutrition and DieteticsSensory Systems3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hair Growth and Disorders Urology 0 works
  2. 2 Muscle Physiology and Disorders Molecular Biology 0 works
  3. 3 Biochemical Analysis and Sensing Techniques Nutrition and Dietetics 0 works
  4. 4 Hearing, Cochlea, Tinnitus, Genetics Sensory Systems 0 works
  5. 5 Peroxisome Proliferator-Activated Receptors Molecular Biology 0 works
  6. 6 Nutrition and Health in Aging Physiology 0 works
  7. 7 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
  8. 8 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
  9. 9 Muscle activation and electromyography studies Biomedical Engineering 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available80.6%not open19.4%

World: 40% of research is openly available.

with international co-authors8.6%domestic only91.4%

World: 18% is written across borders.

How has Caregen (South Korea)'s research output changed?

Output in 2022-2025 was 210% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Anyang-si

All research institutions in Anyang-si

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Caregen (South Korea). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.